+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients?



In patients with heart disease, is the benefit of lipid-lowering therapy with statins similar in older patients to that in younger patients?



Journal of Family Practice 50(11): 924




(PDF emailed within 1 workday: $29.90)

Accession: 046357162

Download citation: RISBibTeXText

PMID: 11711002


Related references

Superior benefit of aggressive lipid-lowering therapy for high- risk patients using statins: the SUBARU study--more hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin therapy. Journal of Atherosclerosis and Thrombosis 15(6): 314-323, 2008

Cost-Effectiveness of Intensifying Lipid-Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients. Journal of the American Heart Association 6(2), 2018

Moderate LDL cholesterol reduction with statins shows similar benefit to aggressive lipid lowering in ischaemic heart disease. BMJ 353: I3437, 2017

Changes of blood lipids in colorectal cancer patients with coronary heart disease and value of lipid-lowering therapy with statins. Nan Fang Yi Ke Da Xue Xue Bao 28(5): 863-865, 2008

Effects of lipid-lowering therapy on coronary heart disease in older patients: the SAGE study. Current Atherosclerosis Reports 10(1): 5-6, 2008

Cholesterol-lowering therapy is more cost-effective for older than younger patients Results from the LIPID study. European Heart Journal 22(Abstract Suppl.): 270, 2001

Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial. Annals of Internal Medicine 134(10): 931-940, 2001

Similar Mortality and Morbidity of Orthotopic Heart Transplantation for Patients 70 Years of Age and Older Compared With Younger Patients. Transplantation Proceedings 48(8): 2782-2791, 2016

Quality of lipid-lowering therapy in patients with ischaemic heart disease: a register-based study in 3477 patients. Journal of Internal Medicine 255(3): 367-372, 2004

Chronic kidney disease Do patients with CKD benefit from lipid-lowering therapy?. Nature Reviews Nephrology 8(12): 684-685, 2012

The benefit of early use of lipid-lowering drugs at discharge in patients with acute coronary syndromes is greater in patients with heart failure. European Heart Journal 23(Abstract Suppl.): 418, August-September, 2002

Lipid lowering and weight reduction by home-delivered dietary modification in coronary heart disease patients taking statins. American Journal of Cardiology 87(8): 1000-1003, 2001

Persistence with lipid-lowering therapy: influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients. Journal of Managed Care Pharmacy 10(5): 404-411, 2004

Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease: Results of the Study Assessing Goals in the Elderly (SAGE). Yearbook of Endocrinology 2008: 102-103, 2008

Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Circulation 115(6): 700-707, 2007